⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15056158 | 0.84 | GAA (0.31) | — | |
| SCHEMBL2150032 | 0.69 | IDO1 (0.36) | — | |
| SCHEMBL11486733 | 0.69 | SIGMAR1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL6760431 | 0.68 | ALOX5 (0.39) | — | |
| SCHEMBL8356179 | 0.68 | CYP3A4 (0.36) | — | |
| SCHEMBL20710979 | 0.68 | CHRNB2 (0.31) | — | |
| Hydrochloric Acid SCHEMBL1653598 | 0.67 | AOC1 (0.31) | — | |
| SCHEMBL9199938 | 0.67 | — | — | |
| SCHEMBL17026938 | 0.67 | CHRNB2 (0.33) | — | |
| SCHEMBL22383875 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230117324-A1 | OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2023-04-20 | — | — | US | disclosed |
| CN-110678466-B | Diazanaphthalenes as HPK1 inhibitors | 豪夫迈·罗氏有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2022015624-A1 | SUBSTITUTED DIHYDROPYRAZINEDIONES AS MODULATORS OF THE NMDA RECEPTOR | SCHRÖDINGER, INC. (US) | 2022-01-20 | — | — | WO | disclosed |
| US-20210107920-A1 | OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2021-04-15 | — | — | US | disclosed |
| CN-110678466-A | Naphthyridines as HPK1 inhibitors | 豪夫迈·罗氏有限公司 | 2020-01-10 | — | — | CN | disclosed |
| EP-2872514-A1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014011974-A1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-01-16 | — | — | WO | disclosed |
| EP-0416740-A2 | Novel compounds with renin-inhibiting activity | Beecham Group p.l.c. (GB) | 1991-03-13 | — | — | EP | disclosed |
| US-4451650-A | ANTITUMOR AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1984-05-29 | — | — | US | disclosed |
| US-4451650-A | ANTITUMOR AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1984-05-29 | — | — | US | disclosed |
| EP-0107130-A1 | Pyrido(4,3-b)(1,4) oxazines and pyrido(4,3-b) (1,4)thiazines | Southern Research Institute (US) | 1984-05-02 | — | — | EP | disclosed |
| EP-0107130-A1 | Pyrido(4,3-b)(1,4) oxazines and pyrido(4,3-b) (1,4)thiazines | Southern Research Institute (US) | 1984-05-02 | — | — | EP | disclosed |